To help track where we are on this journey, and to amplify success stories, in this Collection we present studies that assess progress or that showcase interventions that have made a difference.

Opdivo plus Yervoy shows efficacy and manageable safety as first-line treatment for unresectable hepatocellular carcinoma in ...

Hepion Pharmaceuticals has had a turbulent year so far. With a YTD performance of -68.60%, its stock has struggled to gain traction in the market. This starkly contrasts with the broader market, as ...

Alcohol takes on the liver, a vital organ that processes toxins, including alcohol, to keep the body healthy. Women, in ...

Addition of the anti-TIGIT monoclonal antibody tiragolumab to standard first-line treatment resulted in better response rates ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

Fatty liver disease, or hepatic steatosis, occurs when excess fat accumulates in liver cells. Commonly associated with ...

Nonalcoholic fatty liver disease (NAFLD) affects up to 40% of the population in western countries and is one of the most ...

Peptidomics offered new diagnostic insights into the underlying processes of metabolic dyfunction-associated steatotic liver ...

During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S.